Investor desk
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from Navigating the Data.
← Back to Events
Tier 1 Global Networking: High ONCOLOGY CONCLUDED
Navigating the Data — 2026 — Not specified (Bio-IT World Conference and Expo), Boston, USA
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at the University of Florida in Gainesville. The conference will be a day of concurrent paper sessions and a keynote presentation. We welcome p
3 Presentations
1 Companies
Presentation data updated Jun 5, 2026, 11:26 AM UTC
Why This Event Matters
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at the University of Florida in Gainesville.
Industry impact
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at the University of Florida in Gainesville.
Market implications
Expect signals on pricing, formulary strategy, and partnership economics relevant to oncology markets in the US region.
Regulatory implications
Trial readouts and FDA/EMA label-expansion discussions drive near-term catalysts for oncology investors attending this congress.
Investor implications
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from Navigating the Data.
Competitive implications
Competitive positioning among top oncology players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Event Significance
Tier-1 industry catalyst
56 /100 composite
Navigating the Data is a targeted oncology forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: downstream media and analyst follow-through.
- Media coverage 20/20
High follow-on media and sell-side note volume expected within 24–48h of key sessions.
- Speaker quality 14/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
- Historical influence 20/20
Prior editions moved stock prices and label expansions — expect similar volatility windows.
- Company participation 2/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
Nova Pharma Intelligence · Analyst desk
Key Takeaways
- National Cancer Institute carries 3 tracked presentations — map against peer readouts at Navigating the Data.
- Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from Navigating the Data.
- Trial readouts and FDA/EMA label-expansion discussions drive near-term catalysts for oncology investors attending this congress.
Timeline & Milestones
- Pre-event intelligence Complete
3 presentations tracked — Key Data and Companies hubs live.
- Conference opens May 20, 2026 Complete
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Complete
3 Nova articles linked — see Coverage & Analysis.
- Conference closes May 21, 2026 Complete
Post-event recap, competitive takeaways, and trial updates.
Oncology BD teams Clinical development leaders Investors & analysts
Executive Summary
C-level briefThe 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at the University of Florida in Gainesville.
Primary audience: Oncology BD teams · Clinical development leaders · Investors & analysts
Analyst Watch
Regulatory affairs
Trial readouts and FDA/EMA label-expansion discussions drive near-term catalysts for oncology investors attending this congress.
Competitive intelligence
Competitive positioning among top oncology players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Most Anticipated Presentations
Full data hub → ORAL May 20
NCI CRDC at the 2026 Bio-IT World Conference: Navigating the Data Landscape
ORAL May 21
AI Enablement Across CRDC and CCDI
POSTER May 20
NCI Cancer Research Data Commons: Lessons Learned and Future Directions
Competitive Landscape
Company map →Competitive positioning among top oncology players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Companies to Watch
All companies →Coverage & Analysis
1 articlesRelated News & Research
Research hub →Event Intelligence Summary
Standalone summaries for Navigating the Data — optimized for research and AI retrieval.
Executive Summary
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at the University of Florida in Gainesville.
Analyst View
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at the University of Florida in Gainesville.
Investor View
Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from Navigating the Data.
BD View
BD teams should prioritize networking with presenting companies and services vendors at Navigating the Data, focusing on oncology partnership and licensing opportunities.
Key Facts
- Event
- Navigating the Data
- Focus
- oncology
- Region
- US Americas
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is Navigating the Data?
Navigating the Data is a oncology industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.
Who attends Navigating the Data?
Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on oncology.
Why is Navigating the Data important?
Navigating the Data influences partnership timing, pipeline prioritization, and policy debates that affect oncology markets for the next 12–18 months.
When is Navigating the Data?
Navigating the Data takes place on the scheduled dates.
Where is Navigating the Data held?
Navigating the Data is held in the listed venue.
What companies participate at Navigating the Data?
1+ companies present data or participate in programming at Navigating the Data, spanning large pharma, biotech, and services vendors.
What should investors watch at Navigating the Data?
Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on oncology catalysts during and after Navigating the Data.
What BD opportunities exist at Navigating the Data?
BD teams use Navigating the Data for licensing discussions, co-development talks, and vendor selection across oncology — especially in networking sessions and satellite meetings.
How does Navigating the Data compare with other pharma conferences?
Navigating the Data is a tier-1 global congress for oncology — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.
How do I get NovaPharmaNews coverage of Navigating the Data?
NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for Navigating the Data. Subscribe to event alerts on this page for breaking updates.